Abstract:Objective To investigate the effect of miR-132-3p on the proliferation of endothelial progenitor cells and its regulatory mechanism in order to provide a new theoretical basis for the treatment of deep venous thrombosis. Methods Real-time quantitative PCR (qPCR) was used to detect the expression of miR-132-3p in the plasma and endothelial progenitor cells of 27 healthy volunteers and 22 thrombus patients, and in endothelial progenitor cells under normoxic and hypoxic conditions. The miR-132-3p analogue and the specific siRNA were transferred into endothelial progenitor cells by the electroporation method. The effect of miR-132-3p on the proliferation of endothelial progenitor cells was detected using MMT and Cell Counting Kit-8 (CCK-8) methods. The effects of miR-132-3p on the expression of FOXO1 in endothelial cells were analyzed using the luciferase assay and western blots. Results The expression of miR-132-3p in clinical patients with thrombosis was significantly decreased to 0.45 ± 0.05 times of that of the healthy volunteers (P＜0.05). The expression of miR-132-3p in endothelial progenitor cells under hypoxia was down-regulated to (0.23 ± 0.13) times of that of under normoxia (P＜0.05). The expression of miR-132-3p of experiment group under hypoxia was up-regulated to (15.72 ± 2.06) times of that of control group (P＜0.05). MMT assay showed that the proliferation of cells in the experimental group under hypoxic condition was up-regulated to (7.79 ± 1.37) times of that in the control group (P＜0.01). CCK-8 assay showed that cell proliferation in experimental group was up-regulated to (6.46 ± 0.38) times of that in the control group (P＜0.01). Software analysis showed that FOXO1 was a direct target of miR-132-3p. Luciferase activity of miR-132-3p mimics transfected endothelial progenitor cells under hypoxic conditions were 0.47 times of that in siRNA treatment group. Western blot showed that the expression of FOXO1 protein in endothelial progenitor cells transfected with miR-132-3p mimics in hypoxia was 0.18 times of that in siRNA treatment group. Conclusions Compared with healthy volunteers, miR-132-3p expression in the blood of patients with thrombosis was significantly reduced that can promote transcription of the FOXO1 gene (and protein expression) and inhibit the proliferation of endothelial progenitor cells. It could be closely related to the formation of venous thrombosis.

miR-150 regulates endothelial progenitor cell differentiation via Akt and promotes thrombus resolution

MiR-150 Enhances the Motility of EPCs in Vitro and Promotes EPCs Homing and Thrombus Resolving in Vivo.

MiR‐205 promotes endothelial progenitor cell angiogenesis and deep vein thrombosis recanalization and resolution by targeting PTEN to regulate Akt/autophagy pathway and MMP2 expression

MiR-497-5p Ameliorates Deep Venous Thrombosis by Facilitating Endothelial Progenitor Cell Migration and Angiogenesis by Regulating LITAF

Upregulation of Mir-483-3p Contributes to Endothelial Progenitor Cells Dysfunction in Deep Vein Thrombosis Patients Via SRF.

Downregulation of Mir-125A-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Alleviates Deep Vein Thrombosis in Mice Via Upregulation of MCL-1.

Upregulation of Microrna-126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis Via Its Target Pik3r2

miRNA-130 Promotes Migration and Angiogenesis of Endothelial Progenitor Cells Through PI3K/AKT/mTOR Pathways

Mir-21 Induces Endothelial Progenitor Cells Proliferation and Angiogenesis Via Targeting FASLG and is a Potential Prognostic Marker in Deep Venous Thrombosis

MiR-9 promotes angiogenesis of endothelial progenitor cell to facilitate thrombi recanalization via targeting TRPM7 through PI3K/Akt/autophagy pathway

Up-regulated miR-204-5p promoted the migration, invasion, and angiogenesis of endothelial progenitor cells to enhance the thrombolysis of rats with deep venous thrombosis by targeting SPRED1

Resveratrol Improves Endothelial Progenitor Cell Function Through Mir-138 by Targeting Focal Adhesion Kinase (FAK) and Promotes Thrombus Resolution in Vivo.

miR-10b-5p regulates venous endothelial cells in deep venous thrombosis by targeting MFG-E8

Advances in microRNA regulation of deep vein thrombosis through venous vascular endothelial cells (Review)

MiR-132-3p regulates proliferation of endothelial progenitor cells mediated by FOXO1

LncRNA GUSBP5-AS promotes EPC migration and angiogenesis and deep vein thrombosis resolution by regulating FGF2 and MMP2/9 through the miR-223-3p/FOXO1/Akt pathway

Downregulation of Let-7E-5p Contributes to Endothelial Progenitor Cell Dysfunction in Deep Vein Thrombosis Via Targeting FASLG

Endothelial progenitor cells accelerate the resolution of deep vein thrombosis

Endothelial progenitor cells overexpressing platelet derived growth factor-D facilitate deep vein thrombosis resolution

Non-coding RNAs regulating endothelial progenitor cells for venous thrombosis: promising therapy and innovation

The effect of endothelial progenitor cells transplantation on microenvironments in a murine model of chronic vein thrombosis